ARYL-2-HALOGENOALKYLARYLAMINES. XXI. THE DESIGN OF AGENTS TO EXPLOIT DIFFERENCES IN CELLULAR OXIDATION-REDUCTION POTENTIALS.
D000814:Aniline Compounds; D000818:Animals; D000970:Antineoplastic Agents; D002277:Carcinoma; D002279:Carcinoma 256, Walker; D005021:Ethylamines; D009588:Nitrogen Mustard Compounds; D010084:Oxidation-Reduction; D010600:Pharmacology; D011809:Quinones; D051381:Rats; D012106:Research
D000814:Aniline Compounds; D000970:Antineoplastic Agents; D005021:Ethylamines; D009588:Nitrogen Mustard Compounds; D011809:Quinones
ANILINE COMPOUNDS; ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; ETHYLAMINES; EXPERIMENTAL LAB STUDY; NITROGEN MUSTARD COMPOUNDS; OXIDATION-REDUCTION; PHARMACOLOGY; QUINONES; RATS